Home » Topics » BioWorld Science

BioWorld Science
RSS

Boehringer Ingelheim presents GPR142 agonists

Jan. 22, 2020

DFH Therapeutics and HHS describe betulinic acid derivatives for HIV infection

Jan. 22, 2020

AlzeCure Pharma discloses new Trk-A and Trk-B modulators

Jan. 22, 2020

Yale University divulges let-7 microRNA-activating compounds for endometriosis

Jan. 22, 2020

Catalent patents decorin-containing products for cancer

Jan. 22, 2020

Multitrait analysis predicts glaucoma susceptibility, progression

Jan. 22, 2020

TWIST1 as a new risk gene for coronary artery disease and stroke

Jan. 22, 2020

rVSVN4CT1-EBOVGP1 Ebola virus vaccine demonstrates safety and immunogenicity in phase I study

Jan. 22, 2020

Results from GLP preclinical study of AAV8-hCocH gene therapy

Jan. 22, 2020

TMPRSS11B as a new therapeutic target in NSCLC

Jan. 22, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
EASL spotlight: TUNE-401 advances epigenetic silencing in HBV
BioWorld
Several presentations at EASL highlight a new generation of therapies coming into view, with the work from Tune Therapeutics Inc. standing out as one of the most...